Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.32 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL650587 | 1.00 | ACHE (0.32) | ACHEGPR3HTR2CCYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL153468 | 0.80 | CYP1A2 (0.41) | ACHEGPR3CYP1A2CYP2D6BCHE | |
| Fluoride Ion SCHEMBL1130361 | 0.76 | CYP1A2 (0.45) | ACHEGPR3CYP1A2CYP2D6BCHE | |
| Hydrochloric Acid SCHEMBL2118017 | 0.75 | CNR1 (0.35) | — | |
| Hydrochloric Acid SCHEMBL5952377 | 0.72 | HTR1A (0.30) | — | |
| Hydrochloric Acid SCHEMBL6433415 | 0.71 | DRD2 (0.32) | GPR3CYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL5951962 | 0.71 | HPGD (0.33) | CYP1A2 | |
| SCHEMBL27602853 | 0.70 | GPR3 (0.37) | ACHEGPR3 | |
| Hydrochloric Acid SCHEMBL7192527 | 0.69 | SLC6A4 (0.32) | ACHEGPR3CYP1A2CYP2D6BCHE | |
| Hydrochloric Acid SCHEMBL4079003 | 0.68 | GPR3 (0.35) | GPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8119850-B2 | Process for producing unsaturated hydrocarbon compound | IDEMITSU KOSAN CO., LTD. (JP) | 2012-02-21 | — | — | US | disclosed |
| US-20090030255-A1 | PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030255-A1 | PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND | ALOX12, ALOX15B, ALOX15 | ACHE 3810/4885GPR3 2942/4885HTR2C 1344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.